US Markets
Home›US Markets›Sectors›Eli Lilly wins first UK approval for weight-loss pill…
Eli Lilly wins first UK approval for weight-loss pill Foundayo
The approval extends Lilly's weight-loss pill competition with Novo Nordisk's Wegovy beyond the U.S.
Eli Lilly has received its first approval for its weight-loss pill Foundayo outside the United States, with the company securing authorization in the U.K., CNBC Markets reports.
The U.K. decision expands the reach of Foundayo in the broader weight-loss drug market, putting Lilly further into direct competition with Novo Nordisk's Wegovy beyond its home market.
The latest approval means the weight-loss pill battle that has already played out in the U.S. is now taking hold in another major market, according to CNBC World.
← Newer storyGlobal insured catastrophe losses total $42bn in first half of 2026Older story →Ola Electric, Ather shares jump after EV subsidies extended to FY28